Rofecoxib

罗非考昔

Report date: 2026/05/28 20:00:21
NME

Base Information

Drug NameRofecoxib
Drug Alias NameRofecoxibum罗非昔布CeoxxVioxx AcuteVioxx +[8] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCyclooxygenase-2 inhibitors
TargetsCyclooxygenase-2
Therapy Area/IndicationsLarge intestine neoplasmPainPain, Postoperative +[13] 
Global Approved IndicationsPainDysmenorrheaOsteoarthritis
Approved Indications in ChinaOsteoarthritis
Original Approved Country/TerritoryUnited States
Original Approved Date1999/05/20
Country/TerritoryCanadaUnited StatesUkraine +[10] 
CombinationsNo
Global Highest StatusWithdrawn
Highest Status in ChinaWithdrawn
Originator CompaniesMerck & Co Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesChinese University Of Hong Kong (Cuhk)National Institute Of Dental And Craniofacial Research (Nidcr)Merck & Co Inc +[6] 
Active IndicationsN/A
Inactive IndicationsLarge intestine neoplasmPainPain, Postoperative +[13] 

Other Information

ATC CodeM01AH02
Related LinksWikipediaDrugBankKEGG